Our broad-based transaction experience extends across a range of situations, industries and enterprise values
Categories
Year
Type
Industry
Announced: June 12, 2025Value: $29 billionStatus: ClosedFinancial advisor to Scale AI on its significant new investment from Meta Platforms
Announced: March 7, 2025Value: $26.1 billionStatus: ClosedExclusive financial advisor to Walgreens Boots Alliance on the take-private transaction of WBA by Sycamore Partners
Announced: September 23, 2025Value: €17.4 billionStatus: PendingFinancial advisor to Mediobanca on Banca Monte dei Paschi di Siena's voluntary public tender and exchange offer for Mediobanca's ordinary shares
Announced: January 27, 2025Value: $16.8 billionStatus: PendingFinancial advisor to Emerson on its acquisition of AspenTech
Announced: January 13, 2025Value: $14.6 billionStatus: PendingCenterview acted as lead financial advisor to Intra-Cellular on its sale to Johnson & Johnson
Announced: July 29, 2025Value: $13.6 billionStatus: PendingJoint lead financial advisor to Baker Hughes in its acquisition of Chart Industries
Announced: March 20, 2025Value: $11 billionStatus: ClosedFinancial advisor to QXO on its acquisition of Beacon Roofing Supply
Announced: July 9, 2025Value: $10 billionStatus: PendingExclusive financial advisor to Verona on its sale to Merck
Announced: June 2, 2025Value: Up to $9.5 billionStatus: PendingFinancial advisor to Blueprint on its sale to Sanofi
Announced: April 8, 2025Value: $8.9 billionStatus: PendingFinancial advisor to Anglo American on the demerger of its platinum group metals business, Anglo American Platinum
Announced: August 20, 2025Value: $8.8 billionStatus: PendingFinancial advisor to Lowe's on its acquisition of Foundation Building Materials
Announced: July 24, 2025Value: $8.6 billionStatus: PendingLead financial advisor to Pinnacle Financial Partners on its combination with Synovus Financial Corp.
Announced: May 5, 2025Value: $7.8 billionStatus: ClosedLead financial advisor to Santander on the sale of its stake in Santander Polska and Santander TFI to Erste Group Bank AG
Announced: October 6, 2025Value: $6.75 billionStatus: PendingFinancial advisor to Qualtrics on its acquisition of Press Ganey
Announced: May 27, 2025Value: $4.4 billionStatus: PendingFinancial advisor to Motorola Solutions on its acquisition of Silvus Technologies
Announced: April 28, 2025Value: $3.9 billionStatus: ClosedFinancial advisor to SpringWorks on its sale to Merck KGaA
Announced: July 1, 2025Value: $3.6 billionStatus: PendingLead financial advisor to Santander on its acquisition of TSB Banking Group
Announced: September 17, 2025Value: Up to $3.5 billionStatus: PendingFinancial advisor to 89bio on its sale to Roche
Announced: June 5, 2025Value: $3.4 billionStatus: PendingFinancial advisor to Kimberly-Clark on its sale of a 51% controlling stake in its International Family Care & Professional segment to Suzano S.A.
Announced: January 13, 2025Value: Up to $2.5 billionStatus: PendingCenterview acted as lead financial advisor to Scorpion on its sale to Eli Lilly
Announced: August 12, 2025Value: $2.4 billionStatus: PendingExclusive financial advisor to Solaris Health in its sale to Cardinal Health
Announced: July 23, 2025Value: $2.4 billionStatus: PendingFinancial advisor to Alpha Group International on its acquisition by Corpay
Announced: July 30, 2025Value: $2.1 billionStatus: PendingExclusive financial advisor to Capstan on its sale to AbbVie
Announced: August 11, 2025Value: $2 billionStatus: PendingLead financial advisor to MeridianLink on its acquisition by Centerbridge
Announced: May 14, 2025Value: Up to $2.0 billionStatus: ClosedExclusive financial advisor to Boston Pharmaceuticals on its sale of efimosfermin to GSK
Announced: March 17, 2025Value: $1.95 billionStatus: PendingLead financial advisor to PepsiCo on its acquisition of poppi
Announced: August 29, 2025Value: $1.8 billionStatus: PendingFinancial advisor to Dupont on the divestiture of its Aramids business to Arclin
Announced: February 20, 2025Value: $1.8 billionStatus: PendingFinancial advisor to certain Alani Nu shareholders
Announced: January 14, 2025Value: $1.78 billionStatus: PendingCenterview served as lead financial advisor to Bain Capital and Evident in their sale of Evident's Inspection Technologies division to Wabtec
Announced: August 11, 2025Value: $1.5 billionStatus: PendingSole financial advisor to the Special Committee of WideOpenWest in evaluating the approved take private proposal by DigitalBridge Investments and Crestview Partners
Announced: June 10, 2025Value: Up to $1.35 billionStatus: PendingExclusive financial advisor to Philogen on its agreement to license the exclusive worldwide rights to develop, manufacture and commercialize OncoAPP3 to Bristol-Meyers Squibb
Announced: April 14, 2025Value: $1.325 billionStatus: ClosedLead financial advisor to Lowe's on its acquisition of Artisan Design Group
Announced: August 25, 2025Value: Up to $1.2 billionStatus: PendingExclusive financial advisor to Gilgamesh Pharmaceuticals in its sale to AbbVie
Announced: January 13, 2025Value: Up to $1.15 billionStatus: ClosedExclusive advisor to IDRx on its sale to GSK
Announced: March 17, 2025Value: Up to $1.1 billionStatus: ClosedExclusive financial advisor to Araris on its acquisition by Taiho Pharmaceutical, a subsidiary of Otsuka Holdings
Announced: September 23, 2025Value: $1 billionStatus: PendingFinancial advisor to ADS on its acquisition of National Diversified Sales, the water management business of Norma Group SE
Announced: May 27, 2025Value: Up to $1 billionStatus: PendingExclusive financial advisor to SiteOne on its sale to Eli Lilly
Announced: March 17, 2025Value: Up to $1.0 billionStatus: PendingExclusive financial advisor to EsoBiotec on its acquisition by AstraZeneca
Announced: January 28, 2025Value: Up to $1.0 billionStatus: PendingExclusive financial advisor to Evergreen on its sale to Lantheus
Announced: October 1, 2025Value: Up to $900 millionStatus: PendingExclusive financial advisor to Elektrofi in its acquisition by Halozyme Therapeutics
Announced: January 8, 2025Value: Up to $900 millionStatus: PendingExclusive advisor to Bolt on its sale to Boston Scientific
Announced: June 3, 2025Value: $880 millionStatus: PendingExclusive financial advisor to 8th Avenue on its acquisition by Post Holdings
Announced: January 8, 2025Value: $795 millionStatus: PendingServed as financial advisor to Simple Mills on its sale to Flowers Foods
Announced: July 21, 2025Value: $730 millionStatus: PendingExclusive financial advisor to ZimVie on its acquisition by ARCHIMED
Announced: September 11, 2025Value: $600 millionStatus: PendingLead financial advisor to TPG on its acquisition of GE Vernova's Proficy Software business
Announced: May 1, 2025Value: $600 millionStatus: ClosedExclusive financial advisor to Conagra Brands on its divestiture of the Chef Boyardee brand
Announced: August 29, 2025Value: $585 millionStatus: ClosedLead financial advisor to PepsiCo on its agreement to sell the Rockstar Energy brand in the U.S. and Canada to Celsius, begin distributing Alani Nu and increase its ownership stake in Celsius
Announced: September 3, 2025Value: $500 millionStatus: PendingExclusive financial advisor to Thirty Madison in its sale to Remedy Meds
Announced: May 21, 2025Value: $470 millionStatus: PendingExclusive financial advisor to Vigil Neuroscience on its sale to Sanofi
Announced: June 23, 2025Value: Up to $425 millionStatus: PendingSole financial advisor to Standard BioTools on the strategic sale of its SomaLogic business to Illumina, Inc.
Announced: July 29, 2025Value: Up to $413 millionStatus: PendingExclusive financial advisor to Bausch Health in its acquisition of DURECT Corporation
Announced: August 5, 2025Value: $412 millionStatus: ClosedExclusive financial advisor to Y-mAbs on its sale to SERB Pharmaceuticals
Announced: May 6, 2025Value: $350 millionStatus: PendingFinancial advisor to Masimo on the sale of its Sound United consumer audio business to HARMAN International
Announced: February 25, 2025Value: $300 millionStatus: PendingExclusive financial advisor to ChampionX in its divestiture of US Synthetic to LongRange Capital
Announced: May 16, 2025Value: $270 millionStatus: ClosedExclusive financial advisor to Inozyme on its sale to BioMarin
Announced: June 27, 2025Value: Up to $264 millionStatus: PendingExclusive financial advisor to Neopharmed on its acquisition of the European ORLADEYO business from BioCryst Pharmaceuticals
Announced: January 29, 2025Value: $250 millionStatus: PendingExclusive financial advisor to Henry Schein in its strategic investment by KKR and board change
Announced: September 29, 2025Value: $220 millionStatus: PendingExclusive financial advisor to Lupin on its wholly owned subsidiary Nanomi B.V.'s acquisition of VISUfarma B.V.
Announced: September 25, 2025Value: $146 millionStatus: PendingExclusive financial advisor to AAR on its acquisition of American Distributors Holding Co., LLC ("ADI")
Announced: October 2, 2025Status: PendingFinancial advisor to NetDocuments on its acquisition of eDOCS from OpenText
Announced: September 16, 2025Status: PendingFinancial advisor to Anglo American on its agreement to implement a joint mine plan with Codelco for their adjacent Chilean copper operations
Announced: September 9, 2025Status: PendingFinancial advisor to Anglo American in its merger of equals with Teck Resources
Announced: September 8, 2025Financial exclusive financial advisor to the departing beneficiaries of the Murdoch Family Trust on their agreement to settle litigation between siblings James Murdoch, Prudence MacLeod, Elisabeth Murdoch and their father Rupert Murdoch and brother Lachlan Murdoch
Announced: September 4, 2025Status: CompleteFinancial advisor to Garage Beer on its strategic growth investment from Durational Capital Management
Announced: September 2, 2025Status: PendingExclusive financial advisor to Kraft Heinz on its separation into two independent, publicly traded companies
Announced: September 1, 2025Status: PendingLead financial advisor to CapVest on its majority stake investment STADA Arzneimittel AG
Announced: August 5, 2025Status: PendingFinancial advisor to Francisco Partners on its acquisition of Legal Tech Solutions Provider Elite from TPG and Thomson Reuters
Announced: July 28, 2025Value: $1.95bnStatus: ClosedFinancial advisor to Advance Auto Parts and passive Co-Manager on its high yield bond issuance
Announced: June 23, 2025Status: PendingFinancial advisor to Dr. Squatch on its sale to Unilever
Announced: June 19, 2025Status: PendingExclusive financial advisor to people & baby on the 95% stake sale of its subsidiary Kids First Group Limited to Taaleem
Announced: June 17, 2025Value: Up to $1.3bnStatus: PendingLead financial advisor to Verve on its sale to Lilly
Announced: June 2, 2025Status: ClosedFinancial advisor to Entertainment Partners on its acquisition of CASHét
Announced: May 15, 2025Status: PendingExclusive financial advisor to Aetion on its sale to Datavant
Announced: May 12, 2025Status: PendingExclusive financial advisor to Danone on its acquisition of a majority stake in Kate Farms
Announced: March 25, 2025Status: ClosedFinancial advisor to Descartes on its acquisition of 3GTMS
Announced: March 25, 2025Status: ClosedFinancial advisor to Illumina on changes to its Board of Directors
Announced: March 20, 2025Value: Up to $1.9bnStatus: PendingExclusive financial advisor to Dren on the sale of DR-0201 to Sanofi
Announced: March 20, 2025Status: ClosedFinancial advisor to IDG on its sale of Foundry to Regent
Announced: March 12, 2025Status: ClosedFinancial advisor to Zealand Pharma on its global collaboration and license agreement with Roche
Announced: March 5, 2025Value: $935mmStatus: PendingExclusive financial advisor to Chimerix on its sale to Jazz Pharmaceuticals
Announced: March 5, 2025Status: PendingExclusive investment banker and financial advisor to the Ad Hoc Group of Cutera's convertible note holders in its filing for chapter 11 and subsequent comprehensive restructuring transaction
Announced: March 4, 2025Status: PendingSole financial advisor to Repligen on its acquisition of 908 Devices' Bioprocessing PAT portfolio
Announced: February 28, 2025Status: ClosedFinancial advisor to Apax on its strategic investment in ECI Software Solutions
Announced: February 27, 2025Status: PendingSole financial advisor to Teleflex on its separation transaction and strategic advisor to the company on its value creation framework
Announced: February 6, 2025Status: PendingFinancial advisor to Honeywell on the separation of its Automation and Aerospace businesses into two separate public companies
Announced: January 22, 2025Status: PendingFinancial advisor to Aptiv on its plan to spin-off its Electrical Distribution Systems business
Announced: January 15, 2025Status: PendingExclusive investment banker to JOANN in its filing for chapter 11 bankruptcy
Announced: January 8, 2025Status: PendingExclusive financial advisor to Alacrity on its strategic transaction for long-term growth
Announced: January 6, 2025Status: PendingFinancial advisor to Advent International on its acquisition of Sauer Brands
Announced: January 6, 2025Status: ClosedExclusive financial advisor to The Walt Disney Company in its combination of Hulu and its live TV business with Fubo